Curaleaf Holdings, Inc. Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA

Rang in Aktien #6443
Curaleaf Holdings, Inc. operates as a prominent cannabis company primarily... Curaleaf Holdings, Inc. operates as a prominent cannabis company primarily within the United States, managing its business through both domestic and international operating segments. The company's core activities involve the cultivation, production, and distribution of a diverse range of cannabis products, available through both its retail locations and wholesale channels. Its extensive product catalog includes various cannabis forms such as flowers (e.g., pre-rolls, dry-herb vaporizer cartridges), concentrates for vaping (like pre-filled cartridges and disposable pens), concentrates for dabbing (including distillate droppers), edibles, mints, topical balms, lotions, tinctures, lozenges, and capsules. Additionally, Curaleaf provides hemp-derived CBD and cannabigerol products. Established in 2010, the company is headquartered in New York, New York.
Aktienkurs
$8.14
Marktkapitalisierung
$1.90B
Veränderung (1 Tag)
2.78%
Veränderung (1 Jahr)
81.42%
Land
US
Handel Curaleaf Holdings, Inc. (CURA)

Kategorie

Healthcare
P/B-Verhältnis für Curaleaf Holdings, Inc. (CURA)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Curaleaf Holdings, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Curaleaf Holdings, Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber